Anti-PD1 (RetifanlimAb biosimilar) monoclonal Antibody
Retifanlimab (Zynyz), is an anti-cancer drug used for the treatment of Mercel cell Carcinoma. Retifanlimab is a Programmed death Receptor 1 (PD-1) blocking Monoclonal antobody. Retifanlimab blocks the interaction between PD-1 and its ligands PD-L1/2, and it acts as an immune checkpoint modulator.
Product Specifications
Product Name Alternative
Zynyz
Host
Humanized
Reactivity
Human
Target Antigen
PD-1
Applications
FACS
Components
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Storage Conditions
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing) . Lyophilized antibodies are shipped at ambient temperature.
Applications Notes
FACS 1:100
Isotype
IgG4 (P108S)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
029584-ML405 100 µL
POPDC2 (Popeye Domain-containing Protein 2, Popeye Protein 2, POP2) (MaxLight 405) discontinued
Ask
View Details